期刊档案
Pulmonary Therapy
— · ISSN 2364-1754 · Medicine-Pulmonary and Respiratory Medicine
数据可追溯 · letpub-v8 · 更新于 2026-08-30期刊简介
研究范围与定位
Aims and Scope Pulmonary Therapy is an international, open access, peer-reviewed (single-blind), and rapid publication journal. The scope of the journal is broad and will consider all scientifically sound research from pre-clinical, clinical (all phases), observational, real-world, and health outcomes research around the use of pulmonary therapies, devices, and surgical techniques. Areas of focus include, but are not limited to: asthma; chronic obstructive pulmonary disease; idiopathic pulmonary fibrosis; pulmonary hypertension; cystic fibrosis; lung cancer; respiratory tract disorders; allergic rhinitis and other respiratory allergies; influenza, pneumococcal infection, respiratory syncytial virus and other respiratory infections; and inhalers and other device therapies. The journal is of interest to a broad audience of pharmaceutical and healthcare professionals and publishes original research, reviews, case reports/series, trial protocols and short communications such as commentaries and editorials. Pulmonary Therapy will consider all scientifically sound research be it positive, confirmatory or negative data. Submissions are welcomed whether they relate to an international and/or a country-specific audience, something that is crucially important when researchers are trying to target more specific patient populations. This inclusive approach allows the journal to assist in the dissemination of quality research, which may be considered of insufficient interest by other journals. Rapid Publication The journal’s publication timelines aim for a rapid peer review of 2 weeks. If an article is accepted it will be published 3–4 weeks from acceptance. The rapid timelines are achieved through the combination of a dedicated in-house editorial team, who manage article workflow, and an extensive Editorial and Advisory Board who assist with peer review. This allows the journal to support the rapid dissemination of research, whilst still providing robust peer review. Combined with the journal’s open access model this allows for the rapid, efficient communication of the latest research and reviews, fostering the advancement of pulmonary therapies. Open Access All articles published by Pulmonary Therapy are open access. Personal Service The journal’s dedicated in-house editorial team offer a personal “concierge service” meaning authors will always have an editorial contact able to update them on the status of their manuscript. The editorial team check all manuscripts to ensure that articles conform to the most recent COPE, GPP and ICMJE publishing guidelines. This supports the publication of ethically sound and transparent research. Digital Features and Plain Language Summaries Pulmonary Therapy offers a range of additional features designed to increase the visibility, readership and educational value of the journal’s content. Each article is accompanied by key summary points, giving a time-efficient overview of the content to a wide readership. Articles may be accompanied by plain language summaries to assist readers who have some knowledge of, but not in-depth expertise in, the area to understand the scientific content and overall implications of the article. The journal also provides the option to include various types of digital features including animated abstracts, video abstracts, slide decks, audio slides, instructional videos, infographics, podcasts and animations. All additional features are peer reviewed to the same high standard as the article itself. If you consider that your paper would benefit from the inclusion of a digital feature, please let us know. Our editorial team are able to create high-quality slide decks and infographics in-house, and video abstracts through our partner Research Square, and would be happy to assist in any way we can. For further information about digital features, please contact the journal editor (see ‘Contact the Journal’ for email address), and see the ‘Guidelines for digital features and plain language summaries’ document under ‘Submission guidelines’. For examples of digital features please visit our showcase page https://springerhealthcare.com/expertise/publishing-digital-features/ Publication Fees Upon acceptance of an article, authors will be required to pay the mandatory Rapid Service Fee of €4500/ $5100/ £3650. The journal will consider fee discounts and waivers for developing countries and this is decided on a case by case basis. Peer Review Process Upon submission, manuscripts are assessed by the editorial team to ensure they fit within the aims and scope of the journal and are also checked for plagiarism. All suitable submissions are then subject to a comprehensive single-blind peer review. Reviewers are selected based on their relevant expertise and publication history in the subject area. The journal has an extensive pool of editorial and advisory board members who have been selected to assist with peer review based on the afore-mentioned criteria. At least two extensive reviews are required to make the editorial decision, with the exception of some article types such as Commentaries, Editorials, and Letters which are generally reviewed by one member of the Editorial Board. Where reviewer recommendations are conflicted, the editorial board will be contacted for further advice and a presiding decision. Manuscripts are then either accepted, rejected or authors are required to make major or minor revisions (both reviewer comments and editorial comments may need to be addressed). Once a revised manuscript is re-submitted, it is assessed along with the responses to reviewer comments and if it has been adequately revised it will be accepted for publication. Accepted manuscripts are then copyedited and typeset by the production team before online publication. Appeals against decisions following peer review are considered on a case-by-case basis and should be sent to the journal editor. Preprints We encourage posting of preprints of primary research manuscripts on preprint servers, authors’ or institutional websites, and open communications between researchers whether on community preprint servers or preprint commenting platforms. Posting of preprints is not considered prior publication and will not jeopardize consideration in our journals. Authors should disclose details of preprint posting during the submission process or at any other point during consideration in one of our journals. Once the manuscript is published, it is the author’s responsibility to ensure that the preprint record is updated with a publication reference, including the DOI and a URL link to the published version of the article on the journal website. Please follow the link for further information on preprint sharing: https://www.springer.com/gp/authors-editors/journal-author/journal-author-helpdesk/submission/1302#c16721550 Copyright Pulmonary Therapy's content is published open access under the Creative Commons Attribution-Noncommercial License, which allows users to read, copy, distribute, and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited. The author assigns the exclusive right to any commercial use of the article to Springer. For more information about the Creative Commons Attribution-Noncommercial License, click here: http://creativecommons.org/licenses/by-nc/4.0. Contact For more information about the journal, including pre-submission enquiries, please contact christopher.vautrinot@springer.com.
主要研究主题 OpenAlex 发文统计 · 占比为近似值
- Asthma and respiratory diseasesMedicine18.7%
- Chronic Obstructive Pulmonary Disease (COPD) ResearchMedicine15%
- Inhalation and Respiratory Drug DeliveryMedicine11.9%
- Respiratory and Cough-Related ResearchMedicine8%
- Interstitial Lung Diseases and Idiopathic Pulmonary FibrosisMedicine5.7%
- Respiratory Support and MechanismsMedicine5.2%
- Cystic Fibrosis Research AdvancesMedicine4.8%
- Delphi Technique in ResearchSocial Sciences4.1%
结构化分区
学科分区明细
不同版本、大类与小类分别展示，不将不同评价口径合并为一个分区值。
《新锐期刊分区表》（ 2026年3月发布）
2026-03 · 2 个学科记录
| 类别 | 学科 | 分区 |
|---|---|---|
| 大类 | 医学 | 3区 |
| 小类 | 呼吸系统RESPIRATORY SYSTEM | 3区 |
期刊分区表（ 2025年3月升级版）
2025-03 · 2 个学科记录
| 类别 | 学科 | 分区 |
|---|---|---|
| 大类 | 医学 | 4区 |
| 小类 | 呼吸系统RESPIRATORY SYSTEM | 4区 |
期刊分区表（ 2023年12月旧的升级版）
2023-12 · 未被该版本收录
该期刊未被此版本分区表收录。
指标与活跃度
发文与引用
逐年发文量 OpenAlex 统计 · 累计 362 篇 · 当年数据不完整
| 年份 | 发文量 | 其中 OA | 被引 |
|---|---|---|---|
| 2026 | 44 | 44 | 32 |
| 2025 | 56 | 56 | 158 |
| 2024 | 34 | 34 | 188 |
| 2023 | 36 | 36 | 450 |
| 2022 | 34 | 34 | 362 |
| 2021 | 35 | 35 | 538 |
- 年文章数
- 50LetPub · 2026-09-13
- 两年平均被引（OpenAlex）
- 2.82OpenAlex · 2026-09-13
- h-index
- 34OpenAlex · 2026-09-13
- i10-index
- 106OpenAlex · 2026-09-13
- CiteScore 2026-06
- 4.9LetPub · 2026-09-13
- SJR 2026-06
- 0.82LetPub · 2026-09-13
- SNIP 2026-06
- 1.13LetPub · 2026-09-13
- Gold OA 文章占比
- 100%LetPub · 2026-09-13
- 自引率
- 2.9%LetPub · 2026-09-13
- 收录数据库
- ESCI;ScopusLetPub · 2026-09-13
- 平均审稿速度（社区自报）
- 6 WeeksLetPub · 2026-09-13
社区自报指标置信度为 0.5；不同来源的统计口径与观测时间不同，页面保留各来源原值。
开放获取与费用
出版政策
- 开放获取状态
- 完全开放获取DOAJ
- 文章处理费（APC）
- EUR 5,950 / USD 7,675 / GBP 5,120DOAJ · 2026-09-13
- 费用减免
- 是
- 其他费用
- 否
- 许可证
- CC BY-NC
- 评审方式
- Anonymous peer review
- 投稿到发表（期刊自报）
- 约 6 周DOAJ
- 查重检测
- 是
- APC（其他来源）
- USD 7,400 / EUR 5,750 / GBP 4,900OpenAlex · 2026-09-13
- APC（其他来源）
- GBP 5,120 / USD 7,675 / EUR 5,950LetPub · 2026-09-13
费用与政策以期刊官网为准；不同来源的观测时间可能不同，页面保留各来源原值。
期刊档案
出版与身份
- 期刊ISSN
- 2364-1754
- E-ISSN
- 2364-1746
- 是否OA开放访问
- Yes
- 通讯方式
- CAMPUS, 4 CRINAN ST, LONDON, ENGLAND, N1 9XW
- 出版商
- Springer Nature
- 出版国家或地区
- United Kingdom
- 出版语言
- English
- 出版周期
- 4 issues per year
- 出版年份
- 0
期刊档案
研究范围
- 期刊简介
- Aims and ScopePulmonary Therapy is an international, open access, peer-reviewed (single-blind), and rapid publication journal. The scope of the journal is broad and will consider all scientifically sound research from pre-clinical, clinical (all phases), observational, real-world, and health outcomes research around the use of pulmonary therapies, devices, and surgical techniques.Areas of focus include, but are not limited to: asthma; chronic obstructive pulmonary disease; idiopathic pulmonary fibrosis; pulmonary hypertension; cystic fibrosis; lung cancer; respiratory tract disorders; allergic rhinitis and other respiratory allergies; influenza, pneumococcal infection, respiratory syncytial virus and other respiratory infections; and inhalers and other device therapies.The journal is of interest to a broad audience of pharmaceutical and healthcare professionals and publishes original research, reviews, case reports/series, trial protocols and short communications such as commentaries and editorials. Pulmonary Therapy will consider all scientifically sound research be it positive, confirmatory or negative data. Submissions are welcomed whether they relate to an international and/or a country-specific audience, something that is crucially important when researchers are trying to target more specific patient populations. This inclusive approach allows the journal to assist in the dissemination of quality research, which may be considered of insufficient interest by other journals.Rapid PublicationThe journal’s publication timelines aim for a rapid peer review of 2 weeks. If an article is accepted it will be published 3–4 weeks from acceptance. The rapid timelines are achieved through the combination of a dedicated in-house editorial team, who manage article workflow, and an extensive Editorial and Advisory Board who assist with peer review. This allows the journal to support the rapid dissemination of research, whilst still providing robust peer review. Combined with the journal’s open access model this allows for the rapid, efficient communication of the latest research and reviews, fostering the advancement of pulmonary therapies.Open AccessAll articles published by Pulmonary Therapy are open access.Personal ServiceThe journal’s dedicated in-house editorial team offer a personal “concierge service” meaning authors will always have an editorial contact able to update them on the status of their manuscript. The editorial team check all manuscripts to ensure that articles conform to the most recent COPE, GPP and ICMJE publishing guidelines. This supports the publication of ethically sound and transparent research.Digital Features and Plain Language SummariesPulmonary Therapy offers a range of additional features designed to increase the visibility, readership and educational value of the journal’s content. Each article is accompanied by key summary points, giving a time-efficient overview of the content to a wide readership. Articles may be accompanied by plain language summaries to assist readers who have some knowledge of, but not in-depth expertise in, the area to understand the scientific content and overall implications of the article. The journal also provides the option to include various types of digital features including animated abstracts, video abstracts, slide decks, audio slides, instructional videos, infographics, podcasts and animations. All additional features are peer reviewed to the same high standard as the article itself. If you consider that your paper would benefit from the inclusion of a digital feature, please let us know. Our editorial team are able to create high-quality slide decks and infographics in-house, and video abstracts through our partner Research Square, and would be happy to assist in any way we can. For further information about digital features, please contact the journal editor (see ‘Contact the Journal’ for email address), and see the ‘Guidelines for digital features and plain language summaries’ document under ‘Submission guidelines’.For examples of digital features please visit our showcase page https://springerhealthcare.com/expertise/publishing-digital-features/ Publication FeesUpon acceptance of an article, authors will be required to pay the mandatory Rapid Service Fee of €4500/ $5100/ £3650. The journal will consider fee discounts and waivers for developing countries and this is decided on a case by case basis.Peer Review ProcessUpon submission, manuscripts are assessed by the editorial team to ensure they fit within the aims and scope of the journal and are also checked for plagiarism. All suitable submissions are then subject to a comprehensive single-blind peer review. Reviewers are selected based on their relevant expertise and publication history in the subject area. The journal has an extensive pool of editorial and advisory board members who have been selected to assist with peer review based on the afore-mentioned criteria.At least two extensive reviews are required to make the editorial decision, with the exception of some article types such as Commentaries, Editorials, and Letters which are generally reviewed by one member of the Editorial Board. Where reviewer recommendations are conflicted, the editorial board will be contacted for further advice and a presiding decision. Manuscripts are then either accepted, rejected or authors are required to make major or minor revisions (both reviewer comments and editorial comments may need to be addressed). Once a revised manuscript is re-submitted, it is assessed along with the responses to reviewer comments and if it has been adequately revised it will be accepted for publication. Accepted manuscripts are then copyedited and typeset by the production team before online publication. Appeals against decisions following peer review are considered on a case-by-case basis and should be sent to the journal editor.PreprintsWe encourage posting of preprints of primary research manuscripts on preprint servers, authors’ or institutional websites, and open communications between researchers whether on community preprint servers or preprint commenting platforms. Posting of preprints is not considered prior publication and will not jeopardize consideration in our journals. Authors should disclose details of preprint posting during the submission process or at any other point during consideration in one of our journals. Once the manuscript is published, it is the author’s responsibility to ensure that the preprint record is updated with a publication reference, including the DOI and a URL link to the published version of the article on the journal website.Please follow the link for further information on preprint sharing:https://www.springer.com/gp/authors-editors/journal-author/journal-author-helpdesk/submission/1302#c16721550CopyrightPulmonary Therapy's content is published open access under the Creative Commons Attribution-Noncommercial License, which allows users to read, copy, distribute, and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited. The author assigns the exclusive right to any commercial use of the article to Springer. For more information about the Creative Commons Attribution-Noncommercial License, click here: http://creativecommons.org/licenses/by-nc/4.0.ContactFor more information about the journal, including pre-submission enquiries, please contact christopher.vautrinot@springer.com.
- 涉及的研究方向
- Medicine-Pulmonary and Respiratory Medicine
期刊档案
指标与活跃度
- 2025-2026最新IF（数据来源于网友提供）
- 注册或登录后，查看IF
- 2025-2026自引率
- 2.9%点击查看自引率趋势图
- 五年IF（数据来源于网友提供）
- 2.997数据由网友[蝴蝶1772]收集提供
- h-index
- 暂无h-index数据
- CiteScore （ 2026年6月最新版）
- CiteScoreSJRSNIPCiteScore排名4.900.8151.125学科分区排名百分位大类：Health Professions小类：Respiratory CareQ11 / 5 90% 大类：Health Professions小类：Pulmonary and Respiratory MedicineQ251 / 165 69%
- 年文章数
- 50点击查看年文章数趋势图
- Gold OA文章占比
- 100.00%
- 研究类文章占比：文章 ÷（文章 + 综述）
- 74.00%
期刊档案
分区、收录与风险
- WOS期刊JCR分区 （ 2025-2026年最新版）
- 注册或登录后，查看WOS分区等级
- 期刊分区表预警名单
- 2026年03月发布的新锐学术版：不在预警名单中2025年03月发布的2025版：不在预警名单中2024年02月发布的2024版：不在预警名单中2023年01月发布的2023版：不在预警名单中2021年12月发布的2021版：不在预警名单中2020年12月发布的2020版：不在预警名单中
- SCI期刊收录coverage
- Emerging Sources Citation Index (ESCI)Scopus (CiteScore)Directory of Open Access Journals (DOAJ)
- PubMed Central (PMC)链接
- 访问官方页面 ↗
期刊档案
投稿与评审
来源与统计口径
来源：LetPub 原始详情页 ↗。投稿经验仅展示聚合统计，不公开第三方正文或用户标识。当前聚合样本：暂无。